RTW INVESTMENTS, LP Holdings

RTW INVESTMENTS, LP is an investment fund managing more than 4.34B US dollars. The largest holdings include Alnylam Pharmaceuticals, PTC Therapeutics and Rocket Pharmaceuticals. In Q3 2022 the fund bought assets of total value of 423.9M US dollars and sold assets of total value of 311.59M US dollars.

$4.33B

portfolio value

+13.81%

quarter

-37.43%

1 year

-42.52%

3 years

-134.03%

5 years

RTW INVESTMENTS, LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	17655000	43587000
Q2 2016	59890000	37020000
Q3 2016	113577000	63449000
Q4 2016	49229000	94957000
Q1 2017	99291000	14178000
Q2 2017	111281000	26803000
Q3 2017	85334000	19583000
Q4 2017	97166000	80417000
Q1 2018	515876000	75517000
Q2 2018	381614000	39243000
Q3 2018	288231000	104289000
Q4 2018	-36193000	468952000
Q1 2019	408075000	92543000
Q2 2019	545262000	114286000
Q3 2019	104543000	184196000
Q4 2019	862982000	104516000
Q1 2020	12757000	75463000
Q2 2020	1238786000	241703000
Q3 2020	597263000	157166000
Q4 2020	1919510000	211032000
Q1 2021	1140563000	841202000
Q2 2021	614556000	615036000
Q3 2021	534081000	473310000
Q4 2021	870373000	243495000
Q1 2022	-35150000	1464768000
Q2 2022	-94006000	429917000
Q3 2022	423902000	311586000

RTW INVESTMENTS, LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 7.77% Portfolio value: 336.94M Avg. open price: $94.18 Current price: $226.4 P/L: +140.39% Sold -14.80% shares Q1 2022	share	7.77%	336.94M	$94.18	$226.4	+140.39%	Sold -14.80% shares Q1 2022
Biotechnology PTC Therapeutics, Inc. Portfolio share: 6.50% Portfolio value: 282.15M Avg. open price: $30.93 Current price: $41.12 P/L: +32.93% Bought +11.40% shares Q3 2022	share	6.50%	282.15M	$30.93	$41.12	+32.93%	Bought +11.40% shares Q3 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 5.81% Portfolio value: 252.21M Avg. open price: $27.63 Current price: $19.03 P/L: -31.12% Bought +5.42% shares Q3 2021	share	5.81%	252.21M	$27.63	$19.03	-31.12%	Bought +5.42% shares Q3 2021
Diagnostics & Research Thermo Fisher Scientific Inc. Portfolio share: 5.09% Portfolio value: 220.88M Avg. open price: $586.06 Current price: $557.21 P/L: -4.92% Bought +16.76% shares Q2 2022	share	5.09%	220.88M	$586.06	$557.21	-4.92%	Bought +16.76% shares Q2 2022
Biotechnology Immunocore Holdings plc Portfolio share: 4.82% Portfolio value: 208.95M Avg. open price: $31.76 Current price: $58.07 P/L: +82.86% Bought +11.39% shares Q3 2022	share	4.82%	208.95M	$31.76	$58.07	+82.86%	Bought +11.39% shares Q3 2022
Medical Instruments & Supplies Masimo Corporation Portfolio share: 4.69% Portfolio value: 203.26M Avg. open price: $192.46 Current price: $142.55 P/L: -25.93% Bought +6.59% shares Q3 2022	share	4.69%	203.26M	$192.46	$142.55	-25.93%	Bought +6.59% shares Q3 2022
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 4.34% Portfolio value: 188.21M Avg. open price: $37.76 Current price: $37.72 P/L: -0.11% Bought +15.65% shares Q2 2022	share	4.34%	188.21M	$37.76	$37.72	-0.11%	Bought +15.65% shares Q2 2022
Biotechnology argenx SE Portfolio share: 3.80% Portfolio value: 164.94M Avg. open price: $308.15 Current price: $393.21 P/L: +27.60% Bought +5.55% shares Q3 2022	share	3.80%	164.94M	$308.15	$393.21	+27.60%	Bought +5.55% shares Q3 2022
Medical Devices Penumbra, Inc. Portfolio share: 3.05% Portfolio value: 132.41M Avg. open price: $264.77 Current price: $212 P/L: -19.93% Bought +4.88% shares Q2 2022	share	3.05%	132.41M	$264.77	$212	-19.93%	Bought +4.88% shares Q2 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 3.03% Portfolio value: 131.48M Avg. open price: $116.44 Current price: $92.75 P/L: -20.34% Bought +20.57% shares Q2 2022	share	3.03%	131.48M	$116.44	$92.75	-20.34%	Bought +20.57% shares Q2 2022
Medical Devices Establishment Labs Holdings Inc. Portfolio share: 2.98% Portfolio value: 129.37M Avg. open price: $26.85 Current price: $68.77 P/L: +156.10% Bought +2.16% shares Q2 2022	share	2.98%	129.37M	$26.85	$68.77	+156.10%	Bought +2.16% shares Q2 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 2.88% Portfolio value: 124.72M Avg. open price: $35.82 Current price: $38.12 P/L: +6.42% Bought +0.51% shares Q3 2022	share	2.88%	124.72M	$35.82	$38.12	+6.42%	Bought +0.51% shares Q3 2022
Diagnostics & Research Illumina, Inc. Portfolio share: 2.48% Portfolio value: 107.67M Avg. open price: $334.6 Current price: $213.86 P/L: -36.09% Bought +10.80% shares Q2 2022	share	2.48%	107.67M	$334.6	$213.86	-36.09%	Bought +10.80% shares Q2 2022
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 2.26% Portfolio value: 97.89M Avg. open price: $29.85 Current price: $4.45 P/L: -85.09% Bought +0.26% shares Q3 2022	share	2.26%	97.89M	$29.85	$4.45	-85.09%	Bought +0.26% shares Q3 2022
Biotechnology Ultragenyx Pharmaceutical Inc. Portfolio share: 2.25% Portfolio value: 97.72M Avg. open price: $59.66 Current price: $39.83 P/L: -33.24% Bought +71.85% shares Q3 2022	share	2.25%	97.72M	$59.66	$39.83	-33.24%	Bought +71.85% shares Q3 2022
Diagnostics & Research Natera, Inc. Portfolio share: 2.23% Portfolio value: 96.81M Avg. open price: $43.43 Current price: $40.39 P/L: -7.00% Bought +4.10% shares Q3 2022	share	2.23%	96.81M	$43.43	$40.39	-7.00%	Bought +4.10% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 2.00% Portfolio value: 86.69M Avg. open price: $19.86 Current price: $36.66 P/L: +84.55% Sold -21.35% shares Q1 2022	share	2.00%	86.69M	$19.86	$36.66	+84.55%	Sold -21.35% shares Q1 2022
Biotechnology Avidity Biosciences, Inc. Portfolio share: 1.95% Portfolio value: 84.43M Avg. open price: $21.46 Current price: $11.18 P/L: -47.89% Bought +7.84% shares Q3 2022	share	1.95%	84.43M	$21.46	$11.18	-47.89%	Bought +7.84% shares Q3 2022
Biotechnology Axsome Therapeutics, Inc. Portfolio share: 1.94% Portfolio value: 83.98M Avg. open price: $42.36 Current price: $77.29 P/L: +82.46% Bought +16.27% shares Q3 2022	share	1.94%	83.98M	$42.36	$77.29	+82.46%	Bought +16.27% shares Q3 2022
Medical Devices Cutera, Inc. Portfolio share: 1.86% Portfolio value: 80.73M Avg. open price: $52.15 Current price: $51.65 P/L: -0.96% Bought +16.00% shares Q2 2022	share	1.86%	80.73M	$52.15	$51.65	-0.96%	Bought +16.00% shares Q2 2022
Biotechnology Vericel Corporation Portfolio share: 1.66% Portfolio value: 71.91M Avg. open price: $14.67 Current price: $22.7 P/L: +54.70% Sold -12.01% shares Q3 2022	share	1.66%	71.91M	$14.67	$22.7	+54.70%	Sold -12.01% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 1.50% Portfolio value: 65.03M Avg. open price: $5.35 Current price: $21.89 P/L: +308.89% N/A Q3 2022	share	1.50%	65.03M	$5.35	$21.89	+308.89%	N/A Q3 2022
Medical Devices Axonics, Inc. Portfolio share: 1.44% Portfolio value: 62.33M Avg. open price: $23.05 Current price: $67.47 P/L: +192.67% Sold -25.00% shares Q3 2022	share	1.44%	62.33M	$23.05	$67.47	+192.67%	Sold -25.00% shares Q3 2022
Biotechnology Adicet Bio, Inc. Portfolio share: 1.39% Portfolio value: 60.31M Avg. open price: $18.73 Current price: $20.2 P/L: +7.88% Bought +7.34% shares Q3 2022	share	1.39%	60.31M	$18.73	$20.2	+7.88%	Bought +7.34% shares Q3 2022
Biotechnology ACADIA Pharmaceuticals Inc. Portfolio share: 1.38% Portfolio value: 60.05M Avg. open price: N/A Current price: $15.24 P/L: N/A Sold -13.10% shares Q3 2022	share	1.38%	60.05M	N/A	$15.24	N/A	Sold -13.10% shares Q3 2022
Biotechnology Ventyx Biosciences, Inc. Portfolio share: 1.25% Portfolio value: 54.17M Avg. open price: N/A Current price: $28.09 P/L: N/A N/A Q4 2021	share	1.25%	54.17M	N/A	$28.09	N/A	N/A Q4 2021
Biotechnology PMV Pharmaceuticals, Inc. Portfolio share: 1.20% Portfolio value: 51.84M Avg. open price: $27.53 Current price: $9.89 P/L: -64.08% Sold -0.88% shares Q3 2022	share	1.20%	51.84M	$27.53	$9.89	-64.08%	Sold -0.88% shares Q3 2022
Biotechnology REGENXBIO Inc. Portfolio share: 1.12% Portfolio value: 48.77M Avg. open price: $28.49 Current price: $23.04 P/L: -19.12% Bought +4.98% shares Q3 2021	share	1.12%	48.77M	$28.49	$23.04	-19.12%	Bought +4.98% shares Q3 2021
Biotechnology Stoke Therapeutics, Inc. Portfolio share: 1.08% Portfolio value: 46.88M Avg. open price: $35.12 Current price: $7.16 P/L: -79.62% Bought +0.21% shares Q2 2022	share	1.08%	46.88M	$35.12	$7.16	-79.62%	Bought +0.21% shares Q2 2022
Biotechnology CinCor Pharma, Inc. Portfolio share: 1.05% Portfolio value: 45.61M Avg. open price: N/A Current price: $12.33 P/L: N/A N/A Q1 2022	share	1.05%	45.61M	N/A	$12.33	N/A	N/A Q1 2022
Medical Devices Globus Medical, Inc. Portfolio share: 1.03% Portfolio value: 44.54M Avg. open price: $67.24 Current price: $72.28 P/L: +7.50% Sold -33.33% shares Q3 2022	share	1.03%	44.54M	$67.24	$72.28	+7.50%	Sold -33.33% shares Q3 2022
Biotechnology Milestone Pharmaceuticals Inc. Portfolio share: 0.91% Portfolio value: 39.65M Avg. open price: $17.46 Current price: $4.75 P/L: -72.80% Bought +9.02% shares Q1 2020	share	0.91%	39.65M	$17.46	$4.75	-72.80%	Bought +9.02% shares Q1 2020
Diagnostics & Research Guardant Health, Inc. Portfolio share: 0.90% Portfolio value: 39.07M Avg. open price: $115.35 Current price: $51.95 P/L: -54.96% Sold -21.52% shares Q3 2022	share	0.90%	39.07M	$115.35	$51.95	-54.96%	Sold -21.52% shares Q3 2022
Biotechnology Protagonist Therapeutics, Inc. Portfolio share: 0.81% Portfolio value: 35.21M Avg. open price: $20.62 Current price: $7.8 P/L: -62.17% Sold -12.88% shares Q3 2022	share	0.81%	35.21M	$20.62	$7.8	-62.17%	Sold -12.88% shares Q3 2022
Biotechnology Tarsus Pharmaceuticals, Inc. Portfolio share: 0.80% Portfolio value: 34.63M Avg. open price: $14.6 Current price: $16.74 P/L: +14.66% Bought +0.48% shares Q3 2022	share	0.80%	34.63M	$14.6	$16.74	+14.66%	Bought +0.48% shares Q3 2022
Biotechnology Fulcrum Therapeutics, Inc. Portfolio share: 0.74% Portfolio value: 32.24M Avg. open price: $11.68 Current price: $6.56 P/L: -43.86% Bought +0.62% shares Q3 2022	share	0.74%	32.24M	$11.68	$6.56	-43.86%	Bought +0.62% shares Q3 2022
Biotechnology Bicycle Therapeutics plc Portfolio share: 0.68% Portfolio value: 29.68M Avg. open price: $58.5 Current price: $32.41 P/L: -44.60% Bought +46.82% shares Q1 2022	share	0.68%	29.68M	$58.5	$32.41	-44.60%	Bought +46.82% shares Q1 2022
Drug Manufacturers—Specialty & Generic Avadel Pharmaceuticals plc Portfolio share: 0.66% Portfolio value: 28.76M Avg. open price: $7.52 Current price: $8.75 P/L: +16.29% Bought +6.58% shares Q1 2021	share	0.66%	28.76M	$7.52	$8.75	+16.29%	Bought +6.58% shares Q1 2021
Biotechnology GH Research PLC Portfolio share: 0.58% Portfolio value: 25.20M Avg. open price: N/A Current price: $11.4 P/L: N/A N/A Q2 2021	share	0.58%	25.20M	N/A	$11.4	N/A	N/A Q2 2021
Biotechnology C4 Therapeutics, Inc. Portfolio share: 0.57% Portfolio value: 24.72M Avg. open price: $33.6 Current price: $8.28 P/L: -75.36% Sold -8.90% shares Q3 2022	share	0.57%	24.72M	$33.6	$8.28	-75.36%	Sold -8.90% shares Q3 2022
Health Information Services 10x Genomics, Inc. Portfolio share: 0.42% Portfolio value: 18.21M Avg. open price: $76.02 Current price: $36.57 P/L: -51.90% Sold -33.33% shares Q3 2022	share	0.42%	18.21M	$76.02	$36.57	-51.90%	Sold -33.33% shares Q3 2022
Biotechnology 2seventy bio, Inc. Portfolio share: 0.41% Portfolio value: 17.88M Avg. open price: N/A Current price: $15.36 P/L: N/A N/A Q1 2022	share	0.41%	17.88M	N/A	$15.36	N/A	N/A Q1 2022
Medical Devices Tandem Diabetes Care, Inc. Portfolio share: 0.36% Portfolio value: 15.40M Avg. open price: $90.3 Current price: $42.44 P/L: -53.00% Sold -65.10% shares Q3 2022	share	0.36%	15.40M	$90.3	$42.44	-53.00%	Sold -65.10% shares Q3 2022
Medical Devices Apyx Medical Corporation Portfolio share: 0.35% Portfolio value: 15.25M Avg. open price: $6.43 Current price: $1.88 P/L: -70.78% Bought +0.21% shares Q3 2021	share	0.35%	15.25M	$6.43	$1.88	-70.78%	Bought +0.21% shares Q3 2021
Medical Devices Outset Medical, Inc. Portfolio share: 0.33% Portfolio value: 14.49M Avg. open price: $51.69 Current price: $21.42 P/L: -58.56% Bought +1.11% shares Q2 2022	share	0.33%	14.49M	$51.69	$21.42	-58.56%	Bought +1.11% shares Q2 2022
Diagnostics & Research Castle Biosciences, Inc. Portfolio share: 0.31% Portfolio value: 13.48M Avg. open price: $41.88 Current price: $24.41 P/L: -41.71% Sold -43.42% shares Q3 2022	share	0.31%	13.48M	$41.88	$24.41	-41.71%	Sold -43.42% shares Q3 2022
Diagnostics & Research DermTech, Inc. Portfolio share: 0.28% Portfolio value: 12.35M Avg. open price: $18.37 Current price: $2.46 P/L: -86.61% Bought 0.00% shares Q4 2021	share	0.28%	12.35M	$18.37	$2.46	-86.61%	Bought 0.00% shares Q4 2021
Biotechnology Jounce Therapeutics, Inc. Portfolio share: 0.28% Portfolio value: 11.94M Avg. open price: $6.92 Current price: $0.91 P/L: -86.88% Bought +17.16% shares Q3 2022	share	0.28%	11.94M	$6.92	$0.91	-86.88%	Bought +17.16% shares Q3 2022
Diagnostics & Research Olink Holding AB (publ) Portfolio share: 0.27% Portfolio value: 11.92M Avg. open price: $29.98 Current price: $22 P/L: -26.62% Sold -37.15% shares Q3 2022	share	0.27%	11.92M	$29.98	$22	-26.62%	Sold -37.15% shares Q3 2022
Biotechnology Third Harmonic Bio, Inc. Portfolio share: 0.27% Portfolio value: 11.56M Avg. open price: N/A Current price: $22 P/L: N/A N/A Q3 2022	share	0.27%	11.56M	N/A	$22	N/A	N/A Q3 2022
Biotechnology Oyster Point Pharma, Inc. Portfolio share: 0.26% Portfolio value: 11.48M Avg. open price: $30.94 Current price: $11.11 P/L: -64.09% Sold -0.69% shares Q3 2022	share	0.26%	11.48M	$30.94	$11.11	-64.09%	Sold -0.69% shares Q3 2022
Biotechnology Aadi Bioscience, Inc. Portfolio share: 0.25% Portfolio value: 10.80M Avg. open price: N/A Current price: $13.42 P/L: N/A N/A Q3 2021	share	0.25%	10.80M	N/A	$13.42	N/A	N/A Q3 2021
Biotechnology Allakos Inc. Portfolio share: 0.23% Portfolio value: 10.05M Avg. open price: N/A Current price: $8.14 P/L: N/A N/A Q3 2022	share	0.23%	10.05M	N/A	$8.14	N/A	N/A Q3 2022
Biotechnology Monte Rosa Therapeutics, Inc. Portfolio share: 0.23% Portfolio value: 9.92M Avg. open price: N/A Current price: $9.43 P/L: N/A N/A Q2 2021	share	0.23%	9.92M	N/A	$9.43	N/A	N/A Q2 2021
Shell Companies Health Sciences Acquisitions Corporation 2 Portfolio share: 0.23% Portfolio value: 9.9M Avg. open price: N/A Current price: $9.96 P/L: N/A N/A Q3 2022	share	0.23%	9.9M	N/A	$9.96	N/A	N/A Q3 2022
Biotechnology Immunic, Inc. Portfolio share: 0.20% Portfolio value: 8.72M Avg. open price: $10.21 Current price: $1.34 P/L: -86.88% Bought +2.09% shares Q2 2022	share	0.20%	8.72M	$10.21	$1.34	-86.88%	Bought +2.09% shares Q2 2022
Medical Devices Pulmonx Corporation Portfolio share: 0.18% Portfolio value: 7.67M Avg. open price: $44.12 Current price: $6.18 P/L: -85.99% Sold -33.33% shares Q3 2022	share	0.18%	7.67M	$44.12	$6.18	-85.99%	Sold -33.33% shares Q3 2022
Biotechnology Renovacor, Inc. Portfolio share: 0.17% Portfolio value: 7.56M Avg. open price: $8 Current price: $3.2 P/L: -60.00% Bought +13.34% shares Q1 2022	share	0.17%	7.56M	$8	$3.2	-60.00%	Bought +13.34% shares Q1 2022
Biotechnology UroGen Pharma Ltd. Portfolio share: 0.16% Portfolio value: 7.13M Avg. open price: N/A Current price: $8.31 P/L: N/A N/A Q3 2021	share	0.16%	7.13M	N/A	$8.31	N/A	N/A Q3 2021
Biotechnology Tenaya Therapeutics, Inc. Portfolio share: 0.16% Portfolio value: 7.13M Avg. open price: N/A Current price: $2.42 P/L: N/A N/A Q3 2021	share	0.16%	7.13M	N/A	$2.42	N/A	N/A Q3 2021
Health Information Services Science 37 Holdings, Inc. Portfolio share: 0.16% Portfolio value: 6.96M Avg. open price: $6.31 Current price: $0.61 P/L: -90.34% Bought +0.95% shares Q3 2022	share	0.16%	6.96M	$6.31	$0.61	-90.34%	Bought +0.95% shares Q3 2022
Shell Companies Research Alliance Corp. II Portfolio share: 0.14% Portfolio value: 6.26M Avg. open price: N/A Current price: $10.11 P/L: N/A N/A Q1 2021	share	0.14%	6.26M	N/A	$10.11	N/A	N/A Q1 2021
Shell Companies BCLS Acquisition Corp. Portfolio share: 0.14% Portfolio value: 6.13M Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q4 2020	share	0.14%	6.13M	N/A	$10.04	N/A	N/A Q4 2020
Medical Devices BrainsWay Ltd. Portfolio share: 0.13% Portfolio value: 5.78M Avg. open price: $8.75 Current price: $1.86 P/L: -78.75% Bought +0.01% shares Q3 2021	share	0.13%	5.78M	$8.75	$1.86	-78.75%	Bought +0.01% shares Q3 2021
Medical Instruments & Supplies Akoya Biosciences, Inc. Portfolio share: 0.13% Portfolio value: 5.68M Avg. open price: $12.14 Current price: $12.55 P/L: +3.41% Bought +107.15% shares Q3 2022	share	0.13%	5.68M	$12.14	$12.55	+3.41%	Bought +107.15% shares Q3 2022
Medical Devices 908 Devices Inc. Portfolio share: 0.12% Portfolio value: 5.13M Avg. open price: $19.01 Current price: $9.4 P/L: -50.55% Sold -39.18% shares Q3 2022	share	0.12%	5.13M	$19.01	$9.4	-50.55%	Sold -39.18% shares Q3 2022
Shell Companies ARYA Sciences Acquisition Corp IV Portfolio share: 0.11% Portfolio value: 4.95M Avg. open price: N/A Current price: $10.05 P/L: N/A N/A Q1 2021	share	0.11%	4.95M	N/A	$10.05	N/A	N/A Q1 2021
SUMMIT HEALTHCRE ACQUISTN CO Portfolio share: 0.11% Portfolio value: 4.92M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	0.11%	4.92M	N/A	N/A	N/A	N/A Q2 2021
Shell Companies ARYA Sciences Acquisition Corp V Portfolio share: 0.11% Portfolio value: 4.9M Avg. open price: N/A Current price: $9.97 P/L: N/A N/A Q3 2021	share	0.11%	4.9M	N/A	$9.97	N/A	N/A Q3 2021
Medical Devices Sight Sciences, Inc. Portfolio share: 0.10% Portfolio value: 4.22M Avg. open price: N/A Current price: $11.71 P/L: N/A Sold -33.27% shares Q3 2022	share	0.10%	4.22M	N/A	$11.71	N/A	Sold -33.27% shares Q3 2022
Shell Companies 5:01 Acquisition Corp. Portfolio share: 0.09% Portfolio value: 3.92M Avg. open price: N/A Current price: $10 P/L: N/A N/A Q4 2020	share	0.09%	3.92M	N/A	$10	N/A	N/A Q4 2020
Biotechnology MoonLake Immunotherapeutics Portfolio share: 0.09% Portfolio value: 3.88M Avg. open price: N/A Current price: $10.07 P/L: N/A N/A Q2 2022	share	0.09%	3.88M	N/A	$10.07	N/A	N/A Q2 2022
Biotechnology Immatics N.V. Portfolio share: 0.08% Portfolio value: 3.5M Avg. open price: N/A Current price: $11.13 P/L: N/A N/A Q3 2020	share	0.08%	3.5M	N/A	$11.13	N/A	N/A Q3 2020
Medical Devices TELA Bio, Inc. Portfolio share: 0.08% Portfolio value: 3.32M Avg. open price: $8.72 Current price: $8.6 P/L: -1.39% Sold -61.64% shares Q3 2022	share	0.08%	3.32M	$8.72	$8.6	-1.39%	Sold -61.64% shares Q3 2022
Shell Companies Medicus Sciences Acquisition Corp. Portfolio share: 0.07% Portfolio value: 2.97M Avg. open price: N/A Current price: $10 P/L: N/A N/A Q2 2021	share	0.07%	2.97M	N/A	$10	N/A	N/A Q2 2021
Drug Manufacturers—General Johnson & Johnson Portfolio share: 0.07% Portfolio value: 2.96M Avg. open price: $135.85 Current price: $178.78 P/L: +31.60% Sold -85.51% shares Q1 2022	share	0.07%	2.96M	$135.85	$178.78	+31.60%	Sold -85.51% shares Q1 2022
Diagnostics & Research Exagen Inc. Portfolio share: 0.07% Portfolio value: 2.84M Avg. open price: $17.87 Current price: $2.43 P/L: -86.40% Bought +2.31% shares Q3 2022	share	0.07%	2.84M	$17.87	$2.43	-86.40%	Bought +2.31% shares Q3 2022
Biotechnology Landos Biopharma, Inc. Portfolio share: 0.06% Portfolio value: 2.58M Avg. open price: N/A Current price: $0.23 P/L: N/A Sold -7.02% shares Q3 2022	share	0.06%	2.58M	N/A	$0.23	N/A	Sold -7.02% shares Q3 2022
Biotechnology Roivant Sciences Ltd. Portfolio share: 0.06% Portfolio value: 2.58M Avg. open price: N/A Current price: $6.18 P/L: N/A N/A Q4 2021	share	0.06%	2.58M	N/A	$6.18	N/A	N/A Q4 2021
Biotechnology ESSA Pharma Inc. Portfolio share: 0.06% Portfolio value: 2.38M Avg. open price: $29.05 Current price: $3.47 P/L: -88.06% Sold -50.28% shares Q3 2022	share	0.06%	2.38M	$29.05	$3.47	-88.06%	Sold -50.28% shares Q3 2022
NYXOAH S A Portfolio share: 0.05% Portfolio value: 2.17M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.05%	2.17M	N/A	N/A	N/A	N/A Q3 2021
Biotechnology ASLAN Pharmaceuticals Limited Portfolio share: 0.04% Portfolio value: 1.80M Avg. open price: N/A Current price: $0.53 P/L: N/A Sold -7.20% shares Q3 2022	share	0.04%	1.80M	N/A	$0.53	N/A	Sold -7.20% shares Q3 2022
Biotechnology Nautilus Biotechnology, Inc. Portfolio share: 0.03% Portfolio value: 1.27M Avg. open price: N/A Current price: $1.76 P/L: N/A Sold -45.45% shares Q3 2022	share	0.03%	1.27M	N/A	$1.76	N/A	Sold -45.45% shares Q3 2022
Biotechnology Miromatrix Medical Inc. Portfolio share: 0.03% Portfolio value: 1.22M Avg. open price: N/A Current price: $4.05 P/L: N/A N/A Q2 2021	share	0.03%	1.22M	N/A	$4.05	N/A	N/A Q2 2021
RENOVACOR INC Portfolio share: 0.00% Portfolio value: 28K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.00%	28K	N/A	N/A	N/A	N/A Q3 2021
Biotechnology AGENUS INC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $3.61 Current price: $2.79 P/L: -22.84% Sold -100.00% shares Q3 2022	share	0.00%	0	$3.61	$2.79	-22.84%	Sold -100.00% shares Q3 2022
Health Information Services Minerva Surgical, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.18 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.18	N/A	Sold -100.00% shares Q3 2022
Medical Devices MaxCyte, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $6.99 Current price: $5.43 P/L: -22.32% Sold -100.00% shares Q3 2022	share	0.00%	0	$6.99	$5.43	-22.32%	Sold -100.00% shares Q3 2022
Biotechnology MacroGenics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $26.73 Current price: $6.38 P/L: -76.13% Sold -100.00% shares Q3 2022	share	0.00%	0	$26.73	$6.38	-76.13%	Sold -100.00% shares Q3 2022
Biotechnology La Jolla Pharmaceutical Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $10.83 Current price: $6.22 P/L: -42.59% Sold -100.00% shares Q3 2022	share	0.00%	0	$10.83	$6.22	-42.59%	Sold -100.00% shares Q3 2022
Medical Devices IsoPlexis Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.29 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.29	N/A	Sold -100.00% shares Q3 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $6.72 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$6.72	N/A	Sold -100.00% shares Q3 2022
Medical Devices PROCEPT BioRobotics Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $45.58 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$45.58	N/A	Sold -100.00% shares Q3 2022
Diagnostics & Research Genetron Holdings Limited Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.1 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.1	N/A	Sold -100.00% shares Q3 2022
Biotechnology Pyxis Oncology, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.29 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.29	N/A	Sold -100.00% shares Q3 2022
Medical Devices Quanterix Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $35.68 Current price: $13 P/L: -63.56% Sold -100.00% shares Q3 2022	share	0.00%	0	$35.68	$13	-63.56%	Sold -100.00% shares Q3 2022
Medical Devices Cytek Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $12.33 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$12.33	N/A	Sold -100.00% shares Q3 2022
Medical Devices RxSight, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $13.83 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$13.83	N/A	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies Singular Genomics Systems, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.92 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.92	N/A	Sold -100.00% shares Q3 2022
Health Information Services SomaLogic, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.7 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.7	N/A	Sold -100.00% shares Q3 2022
Biotechnology CytomX Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $5.49 Current price: $1.71 P/L: -68.87% Sold -100.00% shares Q3 2022	share	0.00%	0	$5.49	$1.71	-68.87%	Sold -100.00% shares Q3 2022
Integrated Freight & Logistics Cryoport, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $18.2 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$18.2	N/A	Sold -100.00% shares Q3 2022
Biotechnology Codexis, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.93 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$5.93	N/A	Sold -100.00% shares Q3 2022
Medical Devices Telesis Bio, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.34 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.34	N/A	Sold -100.00% shares Q3 2022
Biotechnology CTI BioPharma Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.61 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$5.61	N/A	Sold -100.00% shares Q3 2022
Medical Devices AVITA Medical, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $6.52 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$6.52	N/A	Sold -100.00% shares Q3 2022
Diagnostics & Research Twist Bioscience Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $30.58 Current price: $27.74 P/L: -9.29% Sold -100.00% shares Q3 2022	share	0.00%	0	$30.58	$27.74	-9.29%	Sold -100.00% shares Q3 2022
Medical Devices Apollo Endosurgery, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $9.99 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$9.99	N/A	Sold -100.00% shares Q3 2022
Medical Devices Align Technology, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $187.96 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$187.96	N/A	Sold -100.00% shares Q3 2022
Biotechnology Veru Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.82 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$5.82	N/A	Sold -100.00% shares Q3 2022
Medicus Sciences Acquisition Corp. Portfolio share: 0.00% Portfolio value: 1K Avg. open price: N/A Current price: $0.09 P/L: N/A N/A Q2 2021	share	0.00%	1K	N/A	$0.09	N/A	N/A Q2 2021

Showing TOP 111 RTW INVESTMENTS, LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of RTW INVESTMENTS, LP?

The biggest position of the RTW INVESTMENTS, LP is Alnylam Pharmaceuticals, Inc. (ALNY) with 7.77% portfolio share worth of 336.94M US dollars.

Top 5 RTW INVESTMENTS, LP's holdings represent 30% of the portfolio:

Alnylam Pharmaceuticals, Inc. (ALNY) – 7.77%
PTC Therapeutics, Inc. (PTCT) – 6.5%
Rocket Pharmaceuticals, Inc. (RCKT) – 5.81%
Thermo Fisher Scientific Inc. (TMO) – 5.09%
Immunocore Holdings plc (IMCR) – 4.82%

Who is the portfolio manager of RTW INVESTMENTS, LP?

The portfolio manager of the RTW INVESTMENTS, LP is .

What is the total asset value of the RTW INVESTMENTS, LP portfolio?

RTW INVESTMENTS, LP total asset value (portfolio value) is 4.34B US dollars.

Who is ?

is the portfolio manager of the RTW INVESTMENTS, LP.

What is (RTW INVESTMENTS, LP) fund performance?

RTW INVESTMENTS, LP's quarterly performance is +13.81%, annualy -37.43%. In the past 3 years, the value of 's portfolio has decreased by -43%. In the past 5 years, the value of the portfolio has decreased by -134%.

What is the RTW INVESTMENTS, LP CIK?

RTW INVESTMENTS, LP's Central Index Key is 0001493215 .

RTW INVESTMENTS, LP Holdings

RTW INVESTMENTS, LP portfolio value:

RTW INVESTMENTS, LP quarter portfolio value change:

RTW INVESTMENTS, LP 1 year portfolio value change:

RTW INVESTMENTS, LP 3 years portfolio value change:

RTW INVESTMENTS, LP 5 years portfolio value change: